hrp0089p2-p201 | Fetal, Neonatal Endocrinology and Metabolism P2 | ESPE2018

Postnatal Growth of Infants with Neonatal Diabetes: Insulin Pump (CSII) Versus Multiple Daily Injection (MDI) Therapy

Alyafie Fawzia , Soliman Ashraf , Sabt Amal , Eldarsy Nagwa , Elgamal Mona

Background: Permanent neonatal diabetes mellitus (PNDM) is a persistent hyperglycaemia diagnosed within the first 6 months of life. A correct genetic diagnosis can affect treatment and clinical outcome. Clinical manifestations at the time of diagnosis include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration and failure to thrive. Insulin production is inadequate, requiring exogenous insulin therapy. The treatment corrects the hyp...

hrp0082p3-d3-751 | Diabetes (4) | ESPE2014

Continuous Glucose Monitoring vs Oral Glucose Tolerance Test and HbA1C in the Evaluation of Glycemic Abnormalities in an Obese Adolescent Before vs After Partial Gastrectomy

Soliman Ashraf , Sabt Aml , Alyafei Fawzia , Eldarsy Nagwa

Background: We compared continuous glucose monitoring (CGMS) (Medtronic) to oral glucose tolerance test (OGTT) and HbA1c in the follow-up of glycemic abnormality in an adolescent girl with morbid obesity and glycemic abnormalities before and after 2 months of partial gastrectomy. This 16-year-old adolescent girl presented with obesity (weight 98 kg, height 158 cm, BMI=39.2 kg/m2), acanthosis nigricans and nocturnal polyuria and polydipsia. Trials to reduce weight th...

hrp0089p2-p060 | Diabetes & Insulin P2 | ESPE2018

Incidence of Childhood Type 1 and Type 2 Diabetes Mellitus in Qatar between 2012–2016

Alyafei Fawziya , Soliman Ashraf , Alkhalaf Fawziya , Waseef Reem , Abdulkayoum Anas , Sayed Ahmed , Eldarsy Nagwa , Sabt Aml

Introduction: The overall age-adjusted incidence of type 1 diabetes (T1DM) varied from 0.1/100,000 per year in China and Venezuela to 36.8/100,000 per year in Sardinia and 36.5/100,000 per year in Finland. This represents a 350-fold variation in the incidence among the 100 populations Worldwide. In the early 1990s, T2DM it was representing about 3 percent only of pediatric diabetes in the United States, but by 2003, T2DM reached about 20 percent of pediatric diabetes.<p cl...

hrp0089p3-p080 | Diabetes &amp; Insulin P3 | ESPE2018

Clinical and Biochemical Characteristics of Familial Type 1 Diabetes Mellitus (FT1DM) Compared to Non-Familial Type 1 DM (T1DM)

Alyafei Fawzia , Soliman Ashraf , Alkhalaf Fawziya , Sabt Amal , Waseef Reem , Eldarsy Nagwa , Abdulkayoum Anas , Umer Fareeda

Introduction: The clinical and genetic characteristics of T1D cases with and without affected family members have been previously studied with varying results. Some investigators found a similarity of presenting features whereas others reported significant differences between the two groups.Patients and methods: This was a cross sectional descriptive study to determine the clinical presentation and prevalence of beta cell autoimmunity (Anti GAD, anti-isl...

hrp0089p3-p081 | Diabetes &amp; Insulin P3 | ESPE2018

Prevalence of Beta-cell Antibodies and Associated Autoimmune Diseases in Children and Adolescents with Type 1 (T1DM) vs Type 2 Diabetes Mellitus (T2DM) in Qatar

Alyafei Fawzia , Soliman Ashraf , Alkhalaf Fawziya , Sabt Aml , Waseef Reem , Eldarsy Nagwa , Algamal Mona

Introduction: Type 1 diabetes (T1DM) is an autoimmune disease with abnormal immune responses to specific β-cell autoantigens, resulting in insulin deficiency. Children and adolescents with T1DM may also develop organ-specific autoimmunity. The most frequently reported disorders are thyroid dysfunction and celiac disease. There are limited previous studies on the prevalence of associated autoimmunity, especially multiple, in children with T1DM.Aim: T...

hrp0097p1-501 | GH and IGFs | ESPE2023

The Predictive Value of using IGF1/Growth Hormone Peak Ratio on growth parameters in Children with Growth Hormone Deficiency (GHD) before and after GH treatment.

Soliman Ashraf , Alyafei Fawzia , Alaaraj Nada , Hamed Noor , Ahmed Shayma , Elsiddig Sohair , Eldarsy Nagwa

Introduction: GH stimulates the production of IGF1; however, their metabolic effects are different. GH has lipolytic and anti-insulin actions while IGF1 has insulin-like actions.Objectives: To investigate the value of using the IGF1/GH peak ratio in relation to the anthropometric data of children with growth hormone deficiency (GHD) before and after a year of GH therapy.Patients and Methods...